Skip to content

The latest company news, press releases, and resources about Servier and everything our company has to offer.

Advanced Search
  • servier logo
     
    06.26.2026
    Servier Presentations at ISPNO 2026 Highlight Neuro-Oncology Leadership and Expanding Glioma Portfolio
  • servier logo
     
    06.25.2026
    Servier Announces First Patient Enrolled in Phase Ib/II Study for the Treatment of a Rare Pediatric Epilepsy Syndrome in the U.S.
  • servier logo
     
    06.01.2026
    Promising Phase 1 Data for Servier's Emiltatug Ledadotin (Emi-Le) in Adenoid Cystic Carcinoma (ACC) Presented at ASCO 2026
  • servier logo
     
    06.01.2026
    Servier to Acquire Edgewise Therapeutics’ Muscular Dystrophy Business
  • servier logo
     
    05.31.2026
    Servier to Present Extended Follow-Up Results from the Phase 3 INDIGO Trial Showing Durable and Sustained Treatment Benefits of VORANIGO® (vorasidenib) at ASCO 2026
Show 5102550100 per page
Media Contacts

Servier Media Relations
USmediarelations@servier.com

Subscribe